DE69208171D1 - Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe - Google Patents

Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe

Info

Publication number
DE69208171D1
DE69208171D1 DE69208171T DE69208171T DE69208171D1 DE 69208171 D1 DE69208171 D1 DE 69208171D1 DE 69208171 T DE69208171 T DE 69208171T DE 69208171 T DE69208171 T DE 69208171T DE 69208171 D1 DE69208171 D1 DE 69208171D1
Authority
DE
Germany
Prior art keywords
active ingredient
active ingredients
delayed release
bile acids
gum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69208171T
Other languages
English (en)
Other versions
DE69208171T2 (de
Inventor
Evaristo Bertone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BONISCONTRO E GAZZONE Srl
Original Assignee
BONISCONTRO E GAZZONE Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BONISCONTRO E GAZZONE Srl filed Critical BONISCONTRO E GAZZONE Srl
Publication of DE69208171D1 publication Critical patent/DE69208171D1/de
Application granted granted Critical
Publication of DE69208171T2 publication Critical patent/DE69208171T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69208171T 1991-07-22 1992-05-18 Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe Expired - Fee Related DE69208171T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910550A IT1249686B (it) 1991-07-22 1991-07-22 Preparazioni farmaceutiche orali, a base di acidi biliari, a cessione protratta e controllata con le quali e' possibile adottare una sola somministrazione giornaliera

Publications (2)

Publication Number Publication Date
DE69208171D1 true DE69208171D1 (de) 1996-03-21
DE69208171T2 DE69208171T2 (de) 1996-10-02

Family

ID=11400282

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69208171T Expired - Fee Related DE69208171T2 (de) 1991-07-22 1992-05-18 Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe

Country Status (4)

Country Link
EP (1) EP0524395B1 (de)
AT (1) ATE133864T1 (de)
DE (1) DE69208171T2 (de)
IT (1) IT1249686B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
ES2059262B1 (es) * 1992-10-13 1995-10-01 Boniscontro E Gazzone S R L Composiciones farmaceuticas orales de liberacion sostenida conteniendo acidos biliares.
IT1265074B1 (it) * 1993-05-18 1996-10-30 Istituto Biochimico Italiano Composizione farmaceutica a lento rilascio contenente come sostanza attiva un acido biliare
WO1995011043A1 (fr) * 1993-10-22 1995-04-27 Tsumura & Co. Base pour preparation a liberation entretenue, preparation a liberation entretenue, et procede de production d'une telle preparation
DE19906290A1 (de) * 1999-02-15 2000-08-17 Falk Pharma Gmbh Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IT1212141B (it) * 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.

Also Published As

Publication number Publication date
EP0524395A1 (de) 1993-01-27
ITRM910550A0 (it) 1991-07-22
ATE133864T1 (de) 1996-02-15
IT1249686B (it) 1995-03-09
ITRM910550A1 (it) 1993-01-22
DE69208171T2 (de) 1996-10-02
EP0524395B1 (de) 1996-02-07

Similar Documents

Publication Publication Date Title
CA2009890A1 (en) Valproic acid
CA2258920A1 (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
WO1997012583A3 (en) Stable compositions containing n-propargyl-1-aminoindan
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
AU3311095A (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
NZ235877A (en) Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
ATE353009T1 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
BE1002710A5 (fr) Preparation au diclofenac sodique a effet prolonge.
PT93384A (pt) Processo para a preparacao de um material de revestimento de controlo da libertacao de droga para formulacoes de accao prolongada contendo copolimeros de (met)acrilato
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
CA2120048A1 (en) Pharmaceutical composition having analgesic activity
DE69208171D1 (de) Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
SE8600658D0 (sv) Novel composition of matter
DE60018545D1 (de) Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
DE3783923T3 (de) Einen Wirkstoff und ein in Wasser quellendes Polymer enthaltendes Arzneimittel.
UY24780A1 (es) Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación.
ES2059262A1 (es) Composiciones farmaceuticas orales de liberacion sostenida conteniendo acidos biliares.
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
IT9022371A0 (it) Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti, il loro impiego come farmaci e le composizioni farmaceutiche che li contengono.
AU5766790A (en) Liquid polymer composition, and method of use

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee